Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Switching drugs to the skin

To get to market faster, German dermatology play Switch Biotech AG is profiling drugs that have been approved in various indications and is reformulating them as topical treatments for skin diseases.

As a first example,

Read the full 346 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE